<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-16081</identifier>
<setSpec>0001-6519</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Study of cervical metastases from unknown primary tumour resumen</dc:title>
<dc:description xml:lang="en">Cervical metastases of cancer of an unknown primary tumour (CMUPT) are infrequent but they represent both a diagnostic and therapeutic challenge for ENT physicians. We present a retrospective study over 22 patients with CMUPT diagnosed in our hospital during 13 years (3.4% of the patients with head and neck cancer). The sensitivity of the fine-needle aspiration technique was 94.7%. 54% were N2a, 36% N3 and 9% N2b. 73% were squamous cell carcinoma and 27% were undifferentiated carcinoma. We established our protocol on diagnosis and management: panendoscopy with biopsies of nasopharynx, vallecula and pyriform sinus and ipsilateral tonsillectomy. The primary source was identified in 23% of the series. All squamous cell carcinoma were treated with radical neck surgery plus radiotherapy and the undifferentiated carcinoma with chemotherapy and radiotherapy. The overall survival was 64% at 3 years. The N-stage affected the survival rate (AU)</dc:description>
<dc:publisher>Sanidad y Ediciones (SANED, S.L.)</dc:publisher>
<dc:description xml:lang="es">Las metástasis cervicales por un tumor de origen desconocido (MCOD), aunque infrecuentes, suponen un reto diagnóstico y terapéutico para el otorrinolaringólogo. Presentamos un estudio retrospectivo sobre 22 pacientes con MCOD diagnosticados en nuestro Servicio en un período de 13 años (3,4% de los pacientes con cáncer cérvico-facial). La sensibilidad de la PAAF fue de 94,7%. El 54% correspondieron a N2a, el 9% a N2b, y el 36% a N3. El 73% de los casos fueron carcinomas epidermoides y un 27% eran indiferenciados. Presentamos nuestro protocolo diagnóstico y terapéutico: una panendoscopia con biopsia a ciegas de nasofaringe, vallécula y seno piriforme; y amigdalectomía homolateral asociada. Con su utilización encontramos el tumor primario en un 23 per cent de los casos. Todos los carcinomas epidermoides fueron tratados mediante vaciamiento cervical radical y radioterapia, y los 6 carcinomas indiferenciados fueron tratados mediante quimioterapia y radioterapia. Hemos obtenido una supervivencia global a los tres años del 62%. El estadio N influyó en la supervivencia (AU)</dc:description>
<dc:source>Acta Otorrinolaringol Esp;53(8): 601-606, oct. 2002. graf, tab</dc:source>
<dc:title xml:lang="es">Estudio sobre las metástasis cervicales de primario desconocido</dc:title>
<dc:type>article</dc:type>
<dc:creator>Martín Martín, C</dc:creator>
<dc:creator>Labella Caballero, T</dc:creator>
<dc:creator>Vaamonde, P</dc:creator>
<dc:creator>Río Valeiras, M del</dc:creator>
<dc:language>es</dc:language>
<dc:identifier>ibc-16081</dc:identifier>
<dc:subject>^d3162</dc:subject>
<dc:subject>^d2337^s22064</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d6409^s22064</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d19257</dc:subject>
<dc:subject>^d9560</dc:subject>
<dc:date>200210</dc:date>
</metadata>
</record>
</ibecs-document>
